(Q40890875)

English

Growth inhibitory effects of paclitaxel on human epithelioid sarcoma in vitro: heterogeneity of response and the multidrug resistance phenotype

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 September 2017

Growth inhibitory effects of paclitaxel on human epithelioid sarcoma in vitro: heterogeneity of response and the multidrug resistance phenotype (English)

1 reference

Europe PubMed Central

24 September 2017

multiple drug resistance

1 reference

based on heuristic

inferred from title

epithelioid sarcoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Reinecke P

1

1 reference

Europe PubMed Central

24 September 2017

Knopf C

2

1 reference

Europe PubMed Central

24 September 2017

Schmitz M

3

1 reference

Europe PubMed Central

24 September 2017

Schneider EM

4

1 reference

Europe PubMed Central

24 September 2017

Gabbert HE

5

1 reference

Europe PubMed Central

24 September 2017

Gerharz CD

6

1 reference

Europe PubMed Central

24 September 2017

language of work or name

0 references

publication date

1 April 2000

1 reference

Europe PubMed Central

24 September 2017

1 reference

Europe PubMed Central

24 September 2017

88

1 reference

Europe PubMed Central

24 September 2017

7

1 reference

Europe PubMed Central

24 September 2017

1614-1622

1 reference

Europe PubMed Central

24 September 2017

Epithelioid sarcoma.A sarcoma simulating a granuloma or a carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Characterization and chemosensitivity of a human epithelioid sarcoma cell line (SARCCR 2).

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Epithelioid sarcoma of the Bartholin's gland primarily diagnosed as vulvar carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Taxol binds to polymerized tubulin in vitro

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Taxol binds to cellular microtubules

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Cytoskeletal agents inhibit motility and adherence of human tumor cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Multidirectional differentiation in a newly established human epithelioid sarcoma cell line (GRU-1) with co-expression of vimentin, cytokeratins and neurofilament proteins

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Interclonal heterogeneity in a human epithelioid-sarcoma cell line (GRU-1).

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Growth inhibition in clonal subpopulations of a human epithelioid sarcoma cell line by retinoic acid and tumour necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

The detection of rhodamine 123 efflux at low levels of drug resistance

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Epithelioid sarcoma: clinical behavior and prognostic factors of survival

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Taxol administered as a 120 hour infusion

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. A Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Taxol stabilizes microtubules in mouse fibroblast cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Altered expression of M beta 2, the class II beta-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Epithelioid sarcoma.An analysis of 22 cases indicating the prognostic significance of vascular invasion and regional lymph node metastasis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Divergent effects of taxol on tumor necrosis factor-alpha-mediated cytolysis of ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Cytoskeletal Heterogeneity of an Epithelioid Sarcoma with Expression of Vimentin, Cytokeratins, and Neurofilaments

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Modulation of multidrug resistance: at the threshold

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Antiproliferative effects of paclitaxel (Taxol) on human renal clear cell carcinomas in vitro

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Epithelioid sarcoma. An analysis of fifty-one cases

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Cremophor EL, solvent for paclitaxel, and toxicity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2820000401%2988%3A7%3C1614%3A%3AAID-CNCR16%3E3.0.CO%3B2-X

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(20000401)88:7<1614::AID-CNCR16>3.0.CO;2-X

1 reference

Europe PubMed Central

24 September 2017

1 reference

Europe PubMed Central

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40890875&oldid=1909618706"